The skewer technique combined with phacoemulsification to remove the lens dislocated into the vitreous cavity.

IF 2.3 2区医学 Q2 OPHTHALMOLOGY

Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2024-10-16 DOI:10.1097/IAE.0000000000004305

Zigan Zhou, Binghua Guo, Zhong Lin, Zhixiang Hu, Xingyi Wu, Ronghan Wu

{"title":"The skewer technique combined with phacoemulsification to remove the lens dislocated into the vitreous cavity.","authors":"Zigan Zhou, Binghua Guo, Zhong Lin, Zhixiang Hu, Xingyi Wu, Ronghan Wu","doi":"10.1097/IAE.0000000000004305","DOIUrl":null,"url":null,"abstract":"Purpose: To evaluate the efficacy and safety outcomes of our newly developed skewer technique in the management of lens dislocation.Methods: A total of 21 eyes with lens dislocation were treated with this surgical technique. We focused on best-corrected visual acuity (BCVA), intraocular pressure, and complications of retinal damage at 3 months post-surgery.Results: The mean age of the patients was 60.20 ± 10.73 (range: 41-85) years, and the average axial length was 25.40 ± 2.35 (range: 22.30-32.35) mm. The BCVA at 3 months post-surgery showed a significant improvement compared to preoperative measurements. No intraoperative or postoperative retinal damage occurred in any eyes treated with this new technique.Conclusion: The \"skewer\" technique we developed is an innovative solution for addressing lens dislocation. Phacoemulsification can be performed in the anterior chamber utilizing a light guide to control the position and movement of the lens. This approach eliminates the need for perfluorocarbon liquid or extensive pars plana scleral sclerotomy. Based on postoperative outcomes from a series of patients who underwent this procedure, the technique is highly safe and feasible.","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retina-The Journal of Retinal and Vitreous Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IAE.0000000000004305","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To evaluate the efficacy and safety outcomes of our newly developed skewer technique in the management of lens dislocation.

Methods: A total of 21 eyes with lens dislocation were treated with this surgical technique. We focused on best-corrected visual acuity (BCVA), intraocular pressure, and complications of retinal damage at 3 months post-surgery.

Results: The mean age of the patients was 60.20 ± 10.73 (range: 41-85) years, and the average axial length was 25.40 ± 2.35 (range: 22.30-32.35) mm. The BCVA at 3 months post-surgery showed a significant improvement compared to preoperative measurements. No intraoperative or postoperative retinal damage occurred in any eyes treated with this new technique.

Conclusion: The "skewer" technique we developed is an innovative solution for addressing lens dislocation. Phacoemulsification can be performed in the anterior chamber utilizing a light guide to control the position and movement of the lens. This approach eliminates the need for perfluorocarbon liquid or extensive pars plana scleral sclerotomy. Based on postoperative outcomes from a series of patients who underwent this procedure, the technique is highly safe and feasible.

查看原文本刊更多论文

扦取技术与超声乳化术相结合，将脱位到玻璃体腔内的晶状体取出。

目的：评估我们新开发的晶状体脱位串针技术的疗效和安全性：共有 21 只晶状体脱位的眼睛接受了该手术技术的治疗。我们重点观察了术后 3 个月的最佳矫正视力（BCVA）、眼压和视网膜损伤并发症：患者的平均年龄为 60.20 ± 10.73（范围：41-85）岁，平均轴长为 25.40 ± 2.35（范围：22.30-32.35）毫米。术后 3 个月的 BCVA 与术前相比有明显改善。采用这种新技术治疗的所有眼睛均未发生术中或术后视网膜损伤：结论：我们开发的 "扦入 "技术是解决晶状体脱位的创新方案。乳化手术可以在前房进行，利用光导来控制晶状体的位置和移动。这种方法无需使用全氟碳液或大面积的巩膜旁巩膜切开术。根据一系列接受这种手术的患者的术后效果来看，这项技术非常安全可行。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Retina-The Journal of Retinal and Vitreous Diseases 医学-眼科学

CiteScore

5.70

自引率

9.10%

发文量

554

审稿时长

3-6 weeks

期刊介绍： RETINA® focuses exclusively on the growing specialty of vitreoretinal disorders. The Journal provides current information on diagnostic and therapeutic techniques. Its highly specialized and informative, peer-reviewed articles are easily applicable to clinical practice. In addition to regular reports from clinical and basic science investigators, RETINA® publishes special features including periodic review articles on pertinent topics, special articles dealing with surgical and other therapeutic techniques, and abstract cards. Issues are abundantly illustrated in vivid full color. Published 12 times per year, RETINA® is truly a “must have” publication for anyone connected to this field.